Bessemer Group’s Pharming Group PHAR Stock Holding History

Bessemer Group’s Portfolio PHAR Stock Details PHAR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3	Closed	–	–	2643
2025 Q4	$0	Hold	3	–	–	﹤0.01%	2665
2025 Q3	$0	Buy	+3	New	+$37	﹤0.01%	2668

Other funds holding PHAR

SBCM

Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SmartHarvest Portfolios Poulsbo, Washington $240M AUM

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return

EWA

EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

LFG

Larson Financial Group St Louis, Missouri $3.13B AUM 22.88% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Bessemer Group's PHAR Position: Q1 2026 in Review

Bessemer Group sold out of Pharming Group (PHAR) in Q1 2026, closing a stake of 3 shares.

Bessemer Group first reported a position in PHAR in Q3 2025 and held it in 2 quarters. The position peaked at $0 in Q4 2025. 12 funds tracked by Wall St. Rank hold PHAR as of Q1 2026.

Bessemer Group reported no remaining Pharming Group position as of Q1 2026 after selling out during the quarter.
Bessemer Group sold 3 Pharming Group shares in Q1 2026.
Bessemer Group first reported a position in Pharming Group in Q3 2025 and held it in 2 quarters.
Bessemer Group's Pharming Group position peaked at $0 in Q4 2025.
12 funds tracked by Wall St. Rank held Pharming Group as of Q1 2026.

Based on Bessemer Group's 13F filing for Q1 2026, filed 6 May 2026.